<DOC>
	<DOCNO>NCT01228903</DOCNO>
	<brief_summary>This study test hypothesis uric acid impairs function vessel patient kidney disease</brief_summary>
	<brief_title>Uric Acid Endothelium CKD</brief_title>
	<detailed_description>The purpose study understand effect lower serum uric acid level vascular function individual chronic kidney disease compare effect : 1 ) Allopurinol therapy 2 ) Placebo . Patients receive : 3 month study drug ( either allopurinol placebo ) , assessment serum uric acid level vascular function .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<mesh_term>Uric Acid</mesh_term>
	<criteria>Individuals moderate chronic kidney disease ( CKD stage III ) estimate glomerular filtration rate 3060 mL/min/ 1.73m2 Elevated uric acid level Age range : 18 year old Ability give inform consent Albumin &gt; 3.0 g/dL BMI &lt; 40 kg/m2 Life expectancy &lt; 1.0 year Expected undergo living relate kidney transplant 6 month Pregnant , breast feeding , unwilling use adequate birth control History severe liver disease History severe congestive heart failure History hospitalization within 3 month Active infection , antibiotic History Warfarin Use medication contraindicate allopurinol Uncontrolled hypertension History acute gout Allopurinol History adverse reaction Allopurinol Immunosuppressive therapy within last 1 yr</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>uric acid kidney disease endothelial dysfunction</keyword>
</DOC>